24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pharmaceuticals
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:21
Former Mossad chief and real estate tycoons back controversial Israeli drone company
13:31
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
08:51
Jensen Huang: Nvidia “100% in Israel” despite war
21:56
Israel’s war with Iran costs up to $550 million a day
More stories
Buzz
Most popular
Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Former Mossad chief and real estate tycoons back controversial Israeli drone company
3
Israel’s war with Iran costs up to $550 million a day
4
Israel orders airborne laser system for fighter jets and helicopters
5
Jensen Huang: Nvidia “100% in Israel” despite war
More news
Pharmaceuticals
20 stories about Pharmaceuticals
Can-Fite BioPharma to Raise $3.2 Million in Direct Offering
04.04.19
|
CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
Teva Makes Headway in European Copaxone Patent Case
01.04.19
|
Lilach Baumer
Generic 40 mg versions of the drugmaker's blockbuster drug for multiple sclerosis have been available in Europe since late 2017, but Teva is now making strides in court
Life Science Investment Firm Pontifax Raises $170 Million Fund
22.11.18
|
Meir Orbach
The firm’s new fund, its sixth, will focus on credit loans to pharmaceutical companies planning to go public
Biotech Company Polypid Raises $15 Million
07.11.18
|
Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18
|
Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
China’s CMS Medical Signs Multi-Million Dollar Deal With Israeli Pharma Company Can-Fite
07.08.18
|
Amarelle Wenkert
New York-listed Can-Fite develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
Teva Trending Down Following Underwhelming Second Quarter Revenues
02.08.18
|
Dror Reich
On Thursday, the generic drugmaker announced revenues that fell slightly short of analyst consensus
Mylan Cuts Price of Generic Copaxone Offering by 60%
11.07.18
|
Lilach Baumer
Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Teva to Relocate U.S. Headquarters to New Jersey
08.07.18
|
Lilach Baumer
In December, the Israeli drugmaker announced a far-reaching cost cutting plan to deal with its multi-billion debt
Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight
05.07.18
|
CTech
The deal was announced in March, but intended buyer InSight backed out
Goldman Sachs Sees 16% Upside in Teva Stock
26.06.18
|
Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price
Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering
20.06.18
|
Dror Reich
Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns
31.05.18
|
Dror Reich
The Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries
At Swiss Pharma Company, Women’s Health Gets Personal
23.05.18
|
Lilach Baumer
Ferring Pharmaceuticals recently launched a personalized fertility treatment that supports its hormone therapy with a dosage calculation app
Berkshire Hathaway Solidified its Teva Position in 2018 First Quarter
16.05.18
|
Lilach Baumer
According to a Tuesday filing, Berkshire Hathaway more than doubled its Teva stake during the first quarter of 2018
Israel’s Life Sciences Industry Is Dominated by Small Scale Startups
14.05.18
|
Lilach Baumer
65% of all Israel-based life sciences companies employ 10 people or less, according to a new report
Building on Strong First Quarter, Teva Raises 2018 Outlook
03.05.18
|
Lilach Baumer and Dror Reich
The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations
Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
29.04.18
|
Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
Three Board Members to Leave Distraught Drugmaker Teva
26.04.18
|
Lilach Baumer and Dror Reich
Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years
Previous Articles
More Articles
